Saara Kares

Tampere, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Improving cervical screening risk stratification through extended human papillomavirus genotyping and age-specific data.

Improving cervical screening risk stratification through extended human papillomavirus genotyping and age-specific data.

Journal: European journal of public health

Published: August 17, 2026

Persistent human papillomavirus following mild cytology at screening: implications for age-stratified follow-up and triage.

Persistent human papillomavirus following mild cytology at screening: implications for age-stratified follow-up and triage.

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)

Published: December 16, 2025

Genotype and age shape the risk of persistent high-risk human papillomavirus infections.

Genotype and age shape the risk of persistent high-risk human papillomavirus infections.

Journal: American journal of obstetrics and gynecology

Published: December 04, 2025

Clinical relevance of partial HPV genotyping in cervical cancer screening.

Clinical relevance of partial HPV genotyping in cervical cancer screening.

Journal: Scientific reports

Published: November 14, 2025

Introducing self-sampling for cervical cancer screening: A regional implementation study in Pirkanmaa, Finland.

Introducing self-sampling for cervical cancer screening: A regional implementation study in Pirkanmaa, Finland.

Journal: Acta obstetricia et gynecologica Scandinavica

Published: November 10, 2025

The Milan System SUMP Category: 5-Year Diagnostic Performance.

The Milan System SUMP Category: 5-Year Diagnostic Performance.

Journal: Diagnostic cytopathology

Published: January 01, 2025

The Milan system atypia of undetermined significance: 5-year performance data.

The Milan system atypia of undetermined significance: 5-year performance data.

Journal: Cancer cytopathology

Published: May 14, 2024

Cytohistological findings in HPV-negative cases from HPV primary screening programme: quality assurance study.

Cytohistological findings in HPV-negative cases from HPV primary screening programme: quality assurance study.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: July 13, 2022

Detection and Outcome of Endocervical Atypia in Cytology in Primary HPV Screening Programme.

Detection and Outcome of Endocervical Atypia in Cytology in Primary HPV Screening Programme.

Journal: Diagnostics (Basel, Switzerland)

Published: November 22, 2021

Primary HPV screening for cervical cancer: Results after two screening rounds in a regional screening program in Finland.

Primary HPV screening for cervical cancer: Results after two screening rounds in a regional screening program in Finland.

Journal: Acta obstetricia et gynecologica Scandinavica

Published: May 06, 2020

HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?

HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: March 18, 2019

Implementation of HPV-based cervical cancer screening in an organised regional screening programme: 3 years of experience.

Implementation of HPV-based cervical cancer screening in an organised regional screening programme: 3 years of experience.

Journal: Cytopathology : official journal of the British Society for Clinical Cytology

Published: June 26, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026